Streetbeat News

Products Services

YETI

YETI Holdings is considered undervalued despite a 24% YTD decline. The company reported a 10% revenue increase in Q3 2024, driven by new product launches and international sales growth. YETI is reducing its dependence on China, aiming for 50% of drinkware production outside China by 2025.

Portfolio Pulse from

November 19, 2024 | 1:00 pm

SMCI

Super Micro Computer (NASDAQ: SMCI) is a key player in the AI infrastructure market, known for its modular and open architecture. Despite its strategic position, the company faces significant challenges.

Portfolio Pulse from

November 19, 2024 | 1:00 pm

CGAU

Viscount Mining Corp. and Centerra Gold Inc. have commenced a drilling program at the Cherry Creek property in Nevada, targeting a molybdenum and gold geochemical anomaly.

Portfolio Pulse from

November 19, 2024 | 1:00 pm

WLDS

Wearable Devices Ltd. has introduced a new category of neural wristbands using SNC technology, allowing users to control digital devices through gestures. This innovation comes as demand for face-worn devices rises, with companies like Meta and Snap also making new product announcements.

Portfolio Pulse from

November 19, 2024 | 1:00 pm

TLOFF

Talon Metals Corp. has reported positive results from its Michigan exploration drilling, with significant copper-nickel mineralization found at the Boulderdash target.

Portfolio Pulse from

November 19, 2024 | 12:45 pm

LOW

Lowe's Companies Inc reported better-than-expected third-quarter results, driven by increased demand following hurricanes Helene and Milton. The company saw strong storm-related, professional, and online sales, which compensated for weaker demand in larger DIY items.

Portfolio Pulse from

November 19, 2024 | 12:45 pm

SANA

Levi & Korsinsky is investigating Sana Biotechnology, Inc. for potential violations of federal securities laws after the company announced the suspension of two development programs.

Portfolio Pulse from

November 19, 2024 | 12:45 pm

HRMY

Levi & Korsinsky has initiated an investigation into Harmony Biosciences Holdings, Inc. for potential violations of federal securities laws, following a report by Scorpion Capital raising concerns about Harmony's narcolepsy drug, Wakix.

Portfolio Pulse from

November 19, 2024 | 12:45 pm

CBUS

Cibus and Biographica have announced a collaboration to use AI for advancing disease resistance in canola and oilseed rape. The partnership focuses on identifying gene editing targets for Cibus' disease resistance trait development.

Portfolio Pulse from

November 19, 2024 | 12:45 pm

RHHBY

Neuron23 is utilizing Roche's digital biomarker in its Phase 2 NEULARK trial for NEU-411, targeting early Parkinson's disease.

Portfolio Pulse from

November 19, 2024 | 12:45 pm